These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3898083)

  • 21. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence against suppressor cell involvement in naturally acquired tolerance of a minor histocompatibility antigen.
    Johnson LL
    Transplantation; 1991 Jun; 51(6):1267-71. PubMed ID: 1828638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major-histocompatibility-complex-restricted male skin graft rejection responses in rats.
    Miyamoto M; Sano T; Suzuki K; Fukumoto T
    Transplantation; 1984 Sep; 38(3):284-7. PubMed ID: 6382716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of size and gene dosage on the survival of skin allografts on rats rendered tolerant at birth.
    Silvers WK; Collins NH; Naji M
    J Exp Med; 1983 Feb; 157(2):591-9. PubMed ID: 6337230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosensitivity of suppressor cells in neonatally tolerant rats.
    Holán V; Hasek M; Chutná J
    Transplantation; 1978 Jan; 25(1):27-30. PubMed ID: 339444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes.
    Mohler KM; Streilein JW
    J Immunol; 1987 Oct; 139(7):2211-9. PubMed ID: 2958541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired allo-tolerance to major or minor histocompatibility antigens indifferently contributes to preventing diabetes development in non-obese diabetic (NOD) mice.
    Carnaud C; Legrand B; Olivi M; Peterson LB; Wicker LS; Bach JF
    J Autoimmun; 1992 Oct; 5(5):591-601. PubMed ID: 1418296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRANSPLANTATION TOLERANCE INDUCED IN ADULT MICE BY PROTEIN OVERLOADING OF DONORS.
    LIACOPOULOS P; GOODE JH
    Science; 1964 Dec; 146(3649):1305-7. PubMed ID: 14207456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The adoptive transfer of pregnancy-induced unresponsiveness to male skin grafts with thymus-dependent cells.
    Smith RN; Powell AE
    J Exp Med; 1977 Sep; 146(3):899-904. PubMed ID: 330791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of immunological tolerance to major histocompatibility complex antigens. I. High frequencies of tolerogen-specific cytotoxic T lymphocyte precursors in mice neonatally tolerized to class I major histocompatibility complex antigens.
    Heeg K; Wagner H
    Eur J Immunol; 1985 Jan; 15(1):25-30. PubMed ID: 2578397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
    Mayumi H; Good RA
    Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Test of prolongation of skin graft survival by blood injections provides evidence for presence of a new histocompatibility locus in the B-G region of chicken MHC.
    Vilhelmová M
    Tissue Antigens; 1987 Feb; 29(2):83-92. PubMed ID: 3299872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated cytotoxicity to nonmajor histocompatibility complex alloantigens on mouse epidermal cells. V. Contribution of bone marrow-derived cells to Epa-1 antigen expression.
    Burlingham WJ; Steinmuller D
    Transplantation; 1983 Feb; 35(2):130-5. PubMed ID: 6600858
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
    Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed xenogeneic chimeras (rat + mouse to mouse). Evidence of rat stem cell engraftment, strain-specific transplantation tolerance, and skin-specific antigens.
    Ildstad ST; Boggs SS; Vecchini F; Wren SM; Hronakes ML; Johnson PC; Van den Brink MR
    Transplantation; 1992 Apr; 53(4):815-22. PubMed ID: 1566347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.
    Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF
    Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.
    Madsen JC; Superina RA; Wood KJ; Morris PJ
    Nature; 1988 Mar; 332(6160):161-4. PubMed ID: 3279318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine A-induced acceptance of major histocompatibility complex-incompatible grafts differs immunologically from class I or minor antigen-mismatched grafts accepted in the absence of immunosuppression.
    Lim SM; White DJ; Calne RY
    Transplant Proc; 1987 Oct; 19(5):4252-3. PubMed ID: 3314024
    [No Abstract]   [Full Text] [Related]  

  • 40. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies.
    Cobbold SP; Martin G; Waldmann H
    Eur J Immunol; 1990 Dec; 20(12):2747-55. PubMed ID: 1980112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.